Success Metrics

Active Trials
4(67%)

Phase Distribution

Ph phase_2
1
17%
Ph early_phase_1
1
17%
Ph phase_4
2
33%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Other(1)

Detailed Status

Recruiting3
unknown1
Enrolling by invitation1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
4
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 42 (50.0%)

Trials by Status

unknown117%
enrolling_by_invitation117%
recruiting350%
active_not_recruiting117%

Recent Activity

4 active trials
Showing 5 of 6
enrolling_by_invitationearly_phase_1

Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.

NCT07358234
recruiting

Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP

NCT06398873
active_not_recruitingphase_2

Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

NCT04430179
recruitingphase_4

Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis

NCT04869436
recruitingphase_4

Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)

NCT06665971
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07358234Early Phase 1

Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.

Enrolling By Invitation
NCT06398873

Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP

Recruiting
NCT04430179Phase 2

Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

Active Not Recruiting
NCT04869436Phase 4

Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis

Recruiting
NCT06665971Phase 4

Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)

Recruiting
NCT05529784

Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL)

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6